Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Gelone Steven P. Create: Alert

All | News | Filings
Date FiledTypeDescription
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 5 shares @ $1.3, valued at $6.5
01/04/2023 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 3 shares @ $1.89, valued at $5.7
12/08/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 4 shares @ $2.02, valued at $8.1
12/02/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 3 shares @ $2.25, valued at $6.8
11/08/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 4 shares @ $2.2392, valued at $9
10/11/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 4 shares @ $2.72, valued at $10.9
10/04/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 3 shares @ $2.08, valued at $6.2
09/07/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 89 shares @ $0.1566, valued at $13.9
09/01/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 61 shares @ $0.1646, valued at $10
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/08/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 89 shares @ $0.41, valued at $36.5
04/04/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 61 shares @ $0.42, valued at $25.6
03/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 3,483 shares @ $0.45, valued at $1.6k
Paid exercise price by delivering 73 shares @ $0.48, valued at $35
02/01/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Granted 93,400 options to buy @ $0.45, valued at $42k
Granted 46,700 restricted stock units @ $0
01/10/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 110 shares @ $0.58, valued at $63.8
01/04/2022 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 63 shares @ $0.6, valued at $37.8
12/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/09/2021 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 92 shares @ $1.33, valued at $122.4
11/01/2021 4 Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 63 shares @ $1.15, valued at $72.5
10/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy